CARDINAL HEALTH INC

20 November, 2024

Cardinal Health Shows Promising Growth Potential with Improved Market Ratings and Strategic Initiatives

Cardinal Health has recently shown promising signs of growth and resilience, making it a noteworthy consideration for investors. As of November 20, 2024, the company’s Relative Strength Rating improve...
Read More

19 November, 2024

Cardinal Health Among Pharmaceutical Companies Held Liable in Baltimore's Opioid Crisis, City Secures Over $400 Million in Damages

Cardinal Health finds itself embroiled in ongoing legal challenges related to Baltimore's opioid crisis, along with McKesson and Cencora. Recent developments highlight the serious implications for the...
Read More

18 November, 2024

Cardinal Health Among Pharmaceutical Companies Held Liable in Baltimore's Opioid Crisis, City Secures Over $400 Million in Damages

Cardinal Health finds itself embroiled in ongoing legal challenges related to Baltimore's opioid crisis, along with McKesson and Cencora. Recent developments highlight the serious implications for the...
Read More

17 November, 2024

Cardinal Health Expands Healthcare Portfolio with $4 Billion Acquisitions of GI Alliance and Advanced Diabetes Supply Group

Cardinal Health is making significant strides in its healthcare portfolio with the announcement of two major acquisitions valued nearly at $4 billion. The company has acquired a majority stake in GI A...
Read More